U.S. Markets open in 8 hrs 42 mins
  • S&P Futures

    4,692.50
    -6.50 (-0.14%)
     
  • Dow Futures

    35,691.00
    -55.00 (-0.15%)
     
  • Nasdaq Futures

    16,373.75
    -18.50 (-0.11%)
     
  • Russell 2000 Futures

    2,262.60
    -7.20 (-0.32%)
     
  • Crude Oil

    73.03
    +0.67 (+0.93%)
     
  • Gold

    1,787.70
    +2.20 (+0.12%)
     
  • Silver

    22.45
    +0.02 (+0.10%)
     
  • EUR/USD

    1.1337
    -0.0008 (-0.0680%)
     
  • 10-Yr Bond

    1.5090
    0.0000 (0.00%)
     
  • Vix

    19.90
    -1.99 (-9.09%)
     
  • GBP/USD

    1.3212
    +0.0005 (+0.0396%)
     
  • USD/JPY

    113.6550
    -0.0820 (-0.0721%)
     
  • BTC-USD

    49,885.26
    -647.85 (-1.28%)
     
  • CMC Crypto 200

    1,305.21
    +0.10 (+0.01%)
     
  • FTSE 100

    7,337.05
    -2.85 (-0.04%)
     
  • Nikkei 225

    28,785.23
    -75.39 (-0.26%)
     

Recap: Tandem Diabetes Care Q4 Earnings

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Tandem Diabetes Care (NASDAQ:TNDM) rose in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share increased 450.00% year over year to $0.22, which beat the estimate of $0.12.

Revenue of $168,065,000 higher by 55.04% year over year, which beat the estimate of $141,580,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

The upcoming fiscal year's revenue expected to be between $600,000,000 and $615,000,000.

Details Of The Call

Date: Feb 24, 2021

View more earnings on TNDM

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/272ym8kz

Price Action

52-week high: $123.74

52-week low: $43.69

Price action over last quarter: down 12.29%

Company Overview

Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a user's pocket. The t:flex Insulin Delivery System is used by customers with greater insulin needs. The t:slim G4 Insulin Delivery system is a continuous glucose monitoring enabled pump with a touch screen. Tandem Diabetes also sells pump-related supplies and accessories. Pump sales contribute the majority of revenue. The firm generates virtually all of its revenue in the United States.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.